PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,978.00
Bid: 1,983.00
Ask: 1,984.00
Change: -5.00 (-0.25%)
Spread: 1.00 (0.05%)
Open: 1,983.00
High: 1,991.00
Low: 1,971.00
Prev. Close: 1,983.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Fri, 20th Aug 2021 08:10

(Alliance News) - Softbank-backed investment manager Fortress hasn't abandoned yet its effort to buy Wm Morrison Supermarkets, despite the UK grocer late Thursday agreeing to a new GBP7 billion offer from rival bidder Clayton, Dubilier & Rice.

Fortress on Friday asked Morrisons shareholders to take no action on the new CD&R bid, saying it is "considering its options" with respect to the all-cash offer it made at the start of July and increased at the start of August. It said it will make a further announcement "in due course".

The new CD&R offer has been unanimously accepted by the board of the grocer, and directors have said shareholders should vote in favour of the takeover at a meeting due in early October. This means Morrisons has withdrawn its recommendation for investors to accept a previous GBP6.7 billion takeover deal from a consortium led by Fortress.

Last week, CD&R was given an extended deadline until this afternoon by takeover regulators to say whether it wants to make a new offer for Morrisons, or to walk away.

CD&R had originally been turned down by the Morrisons board over a potential GBP5.5 billion bid. In June, the board said the offer "significantly undervalued Morrisons and its future prospects". Since then CD&R had been pondering whether it should increase its bid for the supermarket chain.

Morrisons shares were up 4.6% at 292.08 pence early Friday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.2% at 7,074.38

----------

Hang Seng: down 1.9% at 24,830.72

Nikkei 225: closed down 1.0% at 27,013.25

DJIA: closed down 66.57 points, or 0.2%, at 34,894.12

S&P 500: closed up 5.53 points, or 0.1%, at 4,405.80

Nasdaq Composite: closed up 15.87 points, or 0.1%, at 14,541.79

----------

EUR: soft at USD1.1679 (USD1.1685)

GBP: down at USD1.3614 (USD1.3666)

USD: down at JPY109.64 (JPY109.75)

Gold: up at USD1,787.40 per ounce (USD1,781.65)

Oil (Brent): up at USD66.62 a barrel (USD66.10)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Friday's Key Economic Events still to come

1100 BST Ireland wholesale price index

----------

Retail sales unexpectedly declined in the UK in July, data from the Office of National Statistics showed. Retail sales volumes fell by 2.5% in July from June, which is significantly below the market consensus cited by FXStreet of a 0.4% gain. On the year before, July's sales rose 2.4%, again well short of market consensus, which had predicted a 6% rise. The ONS also noted July's sales are up 5.8% on the pre-coronavirus pandemic level in February 2020. Food store sales volumes fell by 1.5% in July, following an increase in the previous month, when sales had been boosted by the start of the Euro 2020 football championship. Non-food stores saw a fall of 4.4% in sales in July from June, driven by falls in second-hand goods stores and computer and telecoms equipment stores.

----------

BROKER RATING CHANGES

----------

JPMORGAN RAISES HIKMA PHARMACEUTICAL TARGET TO 3000 (2700) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES BABCOCK INTERNATIONAL TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - PRICE TARGET 410 (260) PENCE

----------

COMPANIES - FTSE 100

----------

AstraZeneca said "positive" results from its Provent Phase III trial show its AZD7442 treatment "achieved a statistically significant reduction in the incidence of symptomatic Covid-19, the trial's primary endpoint." AZD7442, Astra noted, is a combination of two long-acting antibodies. It reduced the risk of developing symptomatic Covid-19 by 77% compared to a placebo. The trial accrued 25 cases of symptomatic Covid-19 at the primary analysis, and pointed to no cases of severe Covid-19 or Covid-19-related deaths in the trial, versus two deaths from the placebo. "AZD7442 is the first antibody combination, non-vaccine, modified to potentially provide long-lasting protection that has demonstrated prevention of Covid-19 in a clinical trial," Astra said.

----------

COMPANIES - FTSE 250

----------

UK retailer Marks & Spencer said it has made a strong start to its financial year that began on April 4, with improving sales and profit. M&S said the easing of restrictions has led to an "encouraging" performance. In the 19 weeks to August 14, total revenue was up 29% from a year ago, and up 4.4% on the same period in financial 2020, meaning two years ago and before the pandemic began. This has been led by an outperformance in Food sales, which are up 11% on a year ago and up 9.6% on two years ago, with retail park locations trading strongly. Clothing & Home sales are up 92% year-on-year, but are still 2.6% below financial 2020. "The change in our approach to trading, including more focussed ranges, fewer promotions and a substantially smaller summer sale, has resulted in full price sales up about 9% on financial 2020," M&S explained. Looking ahead, M&S expects adjusted pretax profit at the upper end of its guided range of GBP300 million to GBP350 million. "Although there has likely been an element of pent-up consumer demand in trading to date, we believe this performance provides strong confirmation of the beneficial effects of the last 18 months 'Never the Same Again' changes," the retailer added.

----------

COMPANIES - MAIN MARKET AND AIM

----------

Irish building materials firm Kingspan reported a "remarkably strong" first half, with revenue surging on the back of high demand. Pretax profit in the six months to June 30 rose to EUR297.5 million from EUR177.5 million a year before, with trading profit up 64% to EUR329 million. Revenue increased 41% year-on-year to EUR2.92 billion from EUR2.07 billion. Kingspan declared a 19.9 euro cents dividend for the first half, after withholding payment last year. "Despite inflation in our input costs, effective price management has helped increase trading margins, with a stand out performance in our largest division - insulated panels. Our strategy of expanding through acquisition and diversifying geographically has continued, with ten acquisitions made during the period across four continents, and a robust balance sheet positioned to support future growth," Chief Executive Gene Murtagh said.

----------

UK online retail investment platform interactive investor has invited several investment banks to propose an initial public offering in London that could value the company at up to GBP2 billion, Sky News reported Thursday. Sky News reported that the fund supermarket has started pitching a potential 2022 flotation to several banks, although according to bankers a formal decision has yet to be made, and will depend on market conditions. Should a flotation take place, it is likely that the Manchester-based firm would be valued in a range of GBP1.5 billion and GBP2.0 billion. Sky News described ii as the second largest fund supermarket, beaten only by FTSE 100 constituent Hargreaves Lansdown, however, it operates differently by using a flat-fee subscription model. For the six months ended June 30, ii reported a 19% rise in net revenue year-on-year to GBP76.1 million from GBP63.8 million, with a 33% rise in new clients to 31,667.

----------

COMPANIES - GLOBAL

----------

US regulators on Thursday filed a new lawsuit accusing Facebook of maintaining an illegal monopoly in social networking, reviving the case two months after it was dismissed by a federal judge. In the amended complaint, the Federal Trade Commission said Facebook's dominance "is protected by high barriers to entry," and that "even an entrant with a superior product cannot succeed against the overwhelming network effects enjoyed by an incumbent personal social network." The lawsuit filed in federal court in the US capital said Facebook used "anticompetitive acquisitions" of potential rivals such as Instagram and WhatsApp to protect its dominance. FTC officials said the deals amounted to "illegal buy-or-bury" schemes. "Facebook lacked the business acumen and technical talent to survive the transition to mobile. After failing to compete with new innovators, Facebook illegally bought or buried them when their popularity became an existential threat," said acting FTC competition bureau chief Holly Vedova in a statement. The lawsuit, which could take years to go through the courts without a settlement, calls for the court to order "divestiture of assets," including WhatsApp and Instagram, to restore competition.

----------

Aiming for a bigger presence in US brick-and-mortar retail, Amazon.com plans to open "several" multi-purpose shopping venues similar to department stores, the Wall Street Journal reported Thursday. The stores will sell household items, electronics and apparel, showcasing Amazon's private-label merchandise, the newspaper said, citing people familiar with the matter. Some of the first stores are expected in California and Ohio, according to the report. The move would come on the heels of Amazon's 2017 acquisition of the Whole Foods Market grocery chain for USD13.7 billion, which significantly expanded the e-commerce firm's presence in physical retail.

----------

Friday's Shareholder Meetings

Zegona Communications PLC - GM re sale of Euskaltel investment

Auction Technology Group PLC - GM re LiveAuctioneers acquisition

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2023 09:39

LONDON BROKER RATINGS: Jefferies raises John Wood to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
3 Aug 2023 15:45

UK dividends calendar - next 7 days

Friday 4 August 
Burberry Group PLCdividend payment date
Bytes Technology Group PLCdividend payment date
Bytes Technology Group PLCspecial dividend payment date
CC Japan Income & Growth Trust PLCdividend payment date
CT UK High Income Trust PLCdividend payment date
Ferguson PLCdividend payment date
Global Smaller Cos Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan European Discovery Trust PLCdividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Mitie Group PLCdividend payment date
NewRiver REIT PLCdividend payment date
Norcros PLCdividend payment date
North American Income Trust PLCdividend payment date
Palace Capital PLCdividend payment date
Premier Miton Group PLCdividend payment date
Regional REIT Ltddividend payment date
Schroder UK Mid Cap Fund PLCdividend payment date
Supermarket Income REIT PLCdividend payment date
Twentyfour Income Fund Ltddividend payment date
Value & Indexed Property Income Trust PLCdividend payment date
Vodafone Group PLCdividend payment date
Vp PLCdividend payment date
Workspace Group PLCdividend payment date
Monday 7 August 
no events scheduled 
Tuesday 8 August 
no events scheduled 
Wednesday 9 August 
National Grid PLCdividend payment date
Record PLCdividend payment date
Thursday 10 August 
abrdn New Dawn Investment Trust PLCex-dividend payment date
Alternative Income REIT PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
Avon Protection PLCex-dividend payment date
Barclays PLCex-dividend payment date
BP PLCex-dividend payment date
Domino's Pizza Group PLCex-dividend payment date
Fresnillo PLCex-dividend payment date
Greencoat Renewables PLCex-dividend payment date
Greencoat UK Wind PLCex-dividend payment date
Halfords Group PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
HSBC Holdings PLCex-dividend payment date
IMI PLCex-dividend payment date
Impax Environmental Markets PLCex-dividend payment date
Informa PLCex-dividend payment date
IP Group PLCex-dividend payment date
Irish Residential Properties REIT PLCex-dividend payment date
Lindsell Train Investment Trust PLCex-dividend payment date
LMS Capital PLCex-dividend payment date
Majedie Investments PLCex-dividend payment date
Man Group PLCex-dividend payment date
NatWest Group PLCex-dividend payment date
PayPoint PLCex-dividend payment date
Pearson PLCex-dividend payment date
PRS REIT PLCex-dividend payment date
Quartix Technologies PLCex-dividend payment date
Reach PLCex-dividend payment date
Residential Secure Income PLCex-dividend payment date
Rio Tinto PLCex-dividend payment date
Safestore Holdings PLCdividend payment date
Scottish American Investment Co PLCex-dividend payment date
Segro PLCex-dividend payment date
Shell PLCex-dividend payment date
Speedy Hire PLCex-dividend payment date
Spirent Communications PLCex-dividend payment date
Standard Chartered PLCex-dividend payment date
Target Healthcare REIT PLCex-dividend payment date
Taylor Maritime Investments Ltdex-dividend payment date
Treatt PLCdividend payment date
Tritax Big Box REIT PLCex-dividend payment date
Vanquis Banking Group PLCex-dividend payment date
Vh Global Sustainable Energy Opportunities PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Aug 2023 09:28

Hikma posts higher interim revenue; ups guidance for Generics business

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it expects a higher full year performance from its Generics business amid interim revenue growth, but reported a drop in profit.

Read more
3 Aug 2023 07:51

Hikma lifts guidance for generics business

(Sharecast News) - Hikma Pharmaceuticals lifted annual revenue and margin guidance for its generics business as first-half core operating profit rose 35%.

Read more
27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Friday 28 July 
AstraZeneca PLCHalf Year Results
AIB Group PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Rightmove PLCHalf Year Results
Standard Chartered PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
Vanquis Banking Group PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Bank of Ireland Group PLCHalf Year Results
GlobalData PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Ricardo PLCTrading Statement
Senior PLCHalf Year Results
Spectris PLCHalf Year Results
Tuesday 1 August 
BP PLCHalf Year Results
Coats Group PLCHalf Year Results
Diageo PLCFull Year Results
Domino's Pizza Group PLCHalf Year Results
Filtronic PLCFull Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Metro Bank PLCHalf Year Results
NWF Group PLCFull Year Results
Robert Walters PLCHalf Year Results
Staffline Group PLCHalf Year Results
System1 Group PLCFull Year Results
Travis Perkins PLCHalf Year Results
Virgin Wines UK PLCTrading Statement
Weir Group PLCHalf Year Results
XP Power LtdHalf Year Results
Wednesday 2 August 
BAE Systems PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Haleon PLCHalf Year Results
Genel Energy PLCHalf Year Results
Ibstock PLCHalf Year Results
IP Group PLCHalf Year Results
Kerry Group PLCHalf Year Results
Permanent TSB Group Holdings PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Thursday 3 August 
Coca-Cola Europacific Partners PLCHalf Year Results
Helios Towers PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Mondi PLCTrading Statement
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Omega Diagnostics Group PLCFull Year Results
Pantheon International PLCFull Year Results
Pets At Home Group PLCQ1 Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Serco Group PLCHalf Year Results
Shaftesbury Capital PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Walker Crips Group PLCFull Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 17:08

Commodity-heavy FTSE 100 lifted by Anglo American, China stimulus hopes

Anglo American shines after production update

*

Read more
20 Jul 2023 11:43

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.

Read more
20 Jul 2023 09:54

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boosted other drugmakers' stock.

Read more
20 Jul 2023 08:53

Hikma surges after tornado damages Pfizer injectables plant

(Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.

Read more
12 Jul 2023 09:27

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
8 Jun 2023 12:03

Director dealings: Hikma non-exec invests, LSE Group share buyback rolls on

(Sharecast News) - Hikma Pharmaceuticals was among those on the list of director buys on Thursday, after a non-executive director added almost £27k worth of shares to his holding.

Read more
22 May 2023 09:23

LONDON BROKER RATINGS: Citigroup cuts Sainsbury to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 May 2023 09:29

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning:

Read more
3 May 2023 16:16

Broker tips: HSBC, Hikma, Pearson

(Sharecast News) - Berenberg upgraded HSBC to 'buy' from 'hold' on Wednesday, keeping the price target at 780p, as it said the bank's return on tangible equity of around 13% and attractive growth potential are undervalued.

Read more
3 May 2023 12:56

RBC Capital lifts Hikma price target, reiterates 'outperform'

(Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.